RESUMO
A critical shortage of skilled healthcare workers is a primary cause of disparate global cancer outcomes. We report participant evaluation of a multidisciplinary preceptorship program. In collaboration with the city of Kumasi, Ghana, Mayo Clinic and the City Cancer Challenge hosted a preceptorship program for comprehensive multidisciplinary breast and cervix cancer training. A total of 14 healthcare workers from Kumasi received two weeks of training at Mayo Clinic in November and December 2021. Each participant and preceptor were requested to complete an anonymous post-participation survey. Of the 14 trainee participants, 10 (71%) completed the survey. All respondents found the program "valuable and applicable to their clinical practice." Ninety percent reported they were able to "review effective and critical elements in the development and expansion of the multidisciplinary team" and able to "solve practical clinical cases as a team". General themes of satisfaction included: (1) organization and administration, (2) clinical observations and demonstrations, (3) guidelines development, and (4) recognizing the central importance of cultivating a team-based approach. Of the 40 preceptors, 16 (40%) completed the survey. All respondents reported they felt the training would meaningfully "influence patient care in Ghana", that participation "added value or joy to their clinical practice," and all wished to "participate in future preceptorship programs". After a focused two-week program, trainees reported high satisfaction, usefulness from observing specialized cancer care, and value in closely observing a multidisciplinary oncology team. Preceptors reported the experience added joy and perspective to their clinical practice and wished to participate in future programs.
Assuntos
Oncologia , Preceptoria , Humanos , Gana , Oncologia/educação , Feminino , Pessoal de Saúde/educação , Equipe de Assistência ao Paciente , Inquéritos e Questionários , Masculino , Avaliação de Programas e Projetos de Saúde , Adulto , Neoplasias da MamaRESUMO
Realizing the potential of user-developed automation software interacting with a treatment planning system (TPS) requires rigorous testing to ensure patient safety and data integrity. We developed an automated test platform to allow comparison of the treatment planning database before and after the execution of a write-enabled script interacting with a commercial TPS (Eclipse, Varian Medical Systems, Palo Alto, CA) using the vendor-provided Eclipse Scripting Application Programming Interface (ESAPI). The C#-application known as Write-Enable Script Testing Engine (WESTE) serializes the treatment planning objects (Patient, Structure Set, PlanSetup) accessible through ESAPI, and then compares the serialization acquired before and after the execution of the script being tested, documenting identified differences to highlight the changes made to the treatment planning data. The first two uses of WESTE demonstrated that the testing platform could acquire and analyze the data quickly (<4 s per test case) and facilitate the clinical implementation of write-enabled scripts.
Assuntos
Radioterapia de Intensidade Modulada , Humanos , Planejamento da Radioterapia Assistida por Computador , Dosagem Radioterapêutica , Software , Planejamento de Assistência ao PacienteRESUMO
In order to model the track structure of clinical mega-voltage photon beams in a reasonable time, it is necessary to use a multi-scale approach incorporating a track-structure algorithm for the regions of interest and a condensed history algorithm for the rest of the geometry. This paper introduces a multi-scale Monte Carlo system, which is used to hand off particle trajectory information between the two algorithms. Since condensed history algorithms ignore electrons with energy below a fixed threshold and those electrons are important to the track structure on the micrometre scale, it is necessary to hand over all charged particles to the track-structure algorithm only in a volume that extends beyond the scoring volume. Additionally, the system is validated against experimental results for radio-isotope gamma spectra.